In a January 15th filing, Representative Julie Johnson (D-Texas) disclosed that she sold between $1,001 and $15,000 worth of UnitedHealth Group stock on December 18th from her Chase Brokerage Account ending in 3935. This sale constitutes part of a broader adjustment in her portfolio, which included similar dispositions in other large-cap healthcare and technology names on the same date. As a member of the House Committee on Energy and Commerce, Johnson’s transaction draws heightened interest from investors tracking insider activity in health insurers.

On October 28th, UnitedHealth Group reported third-quarter earnings of $2.92 per share, exceeding the consensus estimate by $0.05, and posted revenue of $113.16 billion, essentially in line with analysts’ forecasts. The company’s return on equity stood at 19.23% and net margin at 4.04%, with year-over-year revenue growth of 12.2%. In December, the firm paid a quarterly dividend of $2.21 per share (annualized yield of 2.7%), reflecting a payout ratio of 46.14% and reinforcing its commitment to returning capital to shareholders.

Institutional ownership remains high at 87.86%, with North Capital Inc., Sunflower Bank N.A. and Axis Wealth Partners LLC each increasing their stakes by over 1.5% during the third quarter. CFC Planning Co. LLC initiated a position of 12,764 shares valued at approximately $4.4 million, making UNH its fifth-largest holding. On the sell-side, Sanford C. Bernstein and Jefferies Financial Group have raised their target valuations to levels above previous projections, while one major research house downgraded its recommendation to a hold. The consensus among seventeen buy ratings and nine holds gives a moderate buy outlook for the coming year.